Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Renovaro Inc. - Common Stock (NQ:RENB)

0.3158 -0.0062 (-1.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renovaro Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Eliminating Barriers Surrounding Solid Tumors Allows T Cells to Kill Cancerous Cells
Via Investor Brand Network
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
Via Investor Brand Network
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors
Via Investor Brand Network
BioMedNewsBreaks — Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
Via Investor Brand Network
Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy
Via Investor Brand Network
Tracking Off-Label Cancer Treatment Could Ease Future Trials, Remedies
Via Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday! 
Via InvestorPlace
UC San Diego Researchers Suggest Stem Cell Transplantation Could Treat Alzheimer’s
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
From Renovaro Biosciences Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! 
Via InvestorPlace
Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer
Via Investor Brand Network
Australia Brings New HIV Infections to Near Zero
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
Via Investor Brand Network
Exposures Product Safety
Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. 
Via Benzinga
Exposures Product Safety
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDi Cube on Appointment of Expert in Clinical Medicine and Digital Health
Via Investor Brand Network
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders
Via Investor Brand Network
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
Via Investor Brand Network
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.